Influenza Vaccine Effectiveness Against Influenza-Related Mortality in Australian Hospitalized Patients: A Propensity Score Analysis
- PMID: 31903487
- DOI: 10.1093/cid/ciz1238
Influenza Vaccine Effectiveness Against Influenza-Related Mortality in Australian Hospitalized Patients: A Propensity Score Analysis
Abstract
Background: Data on influenza vaccine effectiveness (IVE) against mortality are limited, with no Australian data to guide vaccine uptake. We aimed to assess IVE against influenza-related mortality in Australian hospitalized patients, assess residual confounding in the association between influenza vaccination and mortality, and assess whether influenza vaccination reduces the severity of influenza illness.
Methods: Data were collected between 2010 and 2017 from a national Australian hospital-based sentinel surveillance system using a case-control design. Adults and children admitted to the 17 study hospitals with acute respiratory symptoms were tested for influenza using nucleic acid testing; all eligible test-positive cases, and a subset of test-negative controls, were included. Propensity score analysis and multivariable logistic regression were used to determine the adjusted odds ratio (aOR) of vaccination, with IVE = 1 - aOR × 100%. Residual confounding was assessed by examining mortality in controls.
Results: Over 8 seasons, 14038 patients were admitted with laboratory-confirmed influenza. The primary analysis included 9298 cases and 6451 controls, with 194 cases and 136 controls dying during hospitalization. Vaccination was associated with a 31% (95% confidence interval [CI], 3%-51%; P = .033) reduction in influenza-related mortality, with similar estimates in the National Immunisation Program target group. Residual confounding was identified in patients ≥65 years old (aOR, 1.92 [95% CI, 1.06-3.46]; P = .031). There was no evidence that vaccination reduced the severity of influenza illness (aOR, 1.07 [95% CI, .76-1.50]; P = .713).
Conclusions: Influenza vaccination is associated with a moderate reduction in influenza-related mortality. This finding reinforces the utility of the Australian vaccination program in protecting those most at risk of influenza-related deaths.
Keywords: case-control; influenza vaccination; mortality; propensity score analysis; vaccine effectiveness.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Similar articles
-
Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.Vaccine. 2018 Sep 18;36(39):5916-5925. doi: 10.1016/j.vaccine.2018.07.028. Epub 2018 Aug 1. Vaccine. 2018. PMID: 30077480
-
Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).Euro Surveill. 2016 Jul 28;21(30). doi: 10.2807/1560-7917.ES.2016.21.30.30301. Euro Surveill. 2016. PMID: 27494798
-
Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.Vaccine. 2020 Mar 10;38(12):2715-2724. doi: 10.1016/j.vaccine.2020.01.083. Epub 2020 Feb 6. Vaccine. 2020. PMID: 32033848
-
Effectiveness of Influenza Vaccination in Preventing Hospitalization Due to Influenza in Children: A Systematic Review and Meta-analysis.Clin Infect Dis. 2021 Nov 2;73(9):1722-1732. doi: 10.1093/cid/ciab270. Clin Infect Dis. 2021. PMID: 33772586
-
Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.Influenza Other Respir Viruses. 2021 Jan;15(1):164-174. doi: 10.1111/irv.12786. Epub 2020 Sep 3. Influenza Other Respir Viruses. 2021. PMID: 32885610 Free PMC article. Review.
Cited by
-
In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza.Pathogens. 2023 Apr 7;12(4):571. doi: 10.3390/pathogens12040571. Pathogens. 2023. PMID: 37111457 Free PMC article.
-
Effectiveness of influenza vaccination on in-hospital death in older adults with respiratory diseases.Hum Vaccin Immunother. 2022 Nov 30;18(6):2117967. doi: 10.1080/21645515.2022.2117967. Epub 2022 Sep 12. Hum Vaccin Immunother. 2022. PMID: 36094827 Free PMC article.
-
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.Clin Infect Dis. 2021 Oct 20;73(8):1459-1468. doi: 10.1093/cid/ciab462. Clin Infect Dis. 2021. PMID: 34014274 Free PMC article.
-
Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010-2011 to 2015-2016 Seasons in Ontario, Canada.Clin Infect Dis. 2021 Sep 7;73(5):e1191-e1199. doi: 10.1093/cid/ciaa1862. Clin Infect Dis. 2021. PMID: 33354709 Free PMC article.
-
Spotlight influenza: Estimation of influenza vaccine effectiveness in elderly people with assessment of residual confounding by negative control outcomes, Finland, 2012/13 to 2019/20.Euro Surveill. 2021 Sep;26(36):2100054. doi: 10.2807/1560-7917.ES.2021.26.36.2100054. Euro Surveill. 2021. PMID: 34505568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical